Cardio-Oncology - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions
Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Exercise Therapy and Cardiovascular Toxicity in Cancer
Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2
Lack of Association Between Heart Failure and Incident Cancer
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

Recommandation Statement

201902

JOURNAL：Circulation.

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association

Campia U, American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Cardiovascular and Stroke Nursing.

5144

Keywords: AHA Scientific Statements; cardiovascular diseases; medical oncology; therapeutics

FULL TEXT PDF